Fertilo

Clinical Use

For the Lab:

Fertilo easily integrates into laboratory workstreams with an embryology protocol that any embryologist can easily learn.

Watch full training videos here
Embryologists that have used Fertilo have ranked the protocol as very easy to use.
"The Fertilo protocol is friendly and reproducible. Ovarian support cells are easy to manipulate and incorporate into daily laboratory work."

Embryologist who has used Fertilo
"The design, plan and information provided helped to complete all the steps correctly, resulting in safety and reliability throughout the process."

Embryologist who has used Fertilo

For Physicians:

Fertilo would allow physicians to offer an better option for their patients. Fertilo improves the efficacy of IVM so that it provides a viable alternative to conventional stimulation.

Fertilo involves 0-3 days of gonadotropin injections prior to retrieval of immature oocytes and in vitro maturation with Fertilo, reducing the necessary monitoring and protecting patients from the risks and side effects of lengthy systemic hormonal stimulation. Gameto provides extensive instructions and training resources to our clinical partners. To find out more, register your interest in partnership below.

Fertilo Protocol Overview

Fertilo effectively matures oocytes in vitro, allowing clinics to adopt an efficient minimal stimulation protocol:

For Fertilo's full data package, see Landmark Research

Our Partners

Gameto has partnered with global clinics to collaborate on Fertilo studies and commercialization.
Pranor
Rma
The prelude Network
Extend Fertility
Ovation fertility
Pozitivf
Inception
Ruber
Tambre
Spring
ReproART

Interested in partnering on Fertilo?

Register interest below to partner with Gameto as we commercialize and conduct studies of Fertilo globally.

Partner

If you are interested in partnering with Gameto as we conduct preclinical studies and clinical trials, please fill out our partnership form.

Partner with us

Patient

If you are a patient interested in participating in future clinical trials, please fill out the form below.

Contact us